427736002: Oxaprozin potassium (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Analgesic (substance)\Non-opioid analgesic (substance)\Non-steroidal anti-inflammatory agent (substance)\Oxaprozin potassium (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic acid and/or organic acid derivative\Propionic acid and/or propionic acid derivative (substance)\Oxaprozin potassium (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2690200014 Oxaprozin potassium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2692652014 Oxaprozin potassium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Oxaprozin potassium (substance)	Is a	Oxaprozin	false	Inferred relationship	Some
Oxaprozin potassium (substance)	Is a	Propionic acid and/or propionic acid derivative (substance)	true	Inferred relationship	Some
Oxaprozin potassium (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Oxaprozin	true	Inferred relationship	Some
Oxaprozin potassium (substance)	Is a	Non-steroidal anti-inflammatory agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Oxaprozin potassium 600 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Oxaprozin potassium (substance)	Inferred relationship	Some
Oxaprozin potassium 600 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Oxaprozin potassium (substance)	Inferred relationship	Some	1
Oxaprozin potassium 600 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Oxaprozin potassium (substance)	Inferred relationship	Some	1
Oxaprozin potassium 600 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Oxaprozin potassium (substance)	Inferred relationship	Some	1

This concept is not in any reference sets